Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Blase

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Allergy and Asthma Proceedings|January 9, 2026
An infant with chronic relapsing urticariaCandice N Gard, Jennifer Blase, Aimee Speck
Advances in Pediatrics|June 29, 2025
Pediatric LymphadenopathyDanielle Cameron, Alyssa Stetson, Jennifer Blase, et al.
Infection Control and Hospital Epidemiology|November 15, 2013
Management of neurosurgical instruments and patients exposed to Creutzfeldt-Jakob diseaseErmias D Belay, Jennifer Blase, Lynne M Sehulster, et al.
Chemical Biology & Drug Design|February 12, 2009
A potent gelatinase inhibitor with anti-tumor-invasive activity and its metabolic dispositionMijoon Lee, Giuseppe Celenza, Bill Boggess, et al.
Ebiomedicine|September 25, 2024
Crowd-sourced machine learning prediction of long COVID using data from the National COVID Cohort CollaborativeTimothy Bergquist, Johanna Loomba, Emily Pfaff, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Allergy and Asthma Proceedings|January 9, 2026
An infant with chronic relapsing urticariaCandice N Gard, Jennifer Blase, Aimee Speck
Advances in Pediatrics|June 29, 2025
Pediatric LymphadenopathyDanielle Cameron, Alyssa Stetson, Jennifer Blase, et al.
Infection Control and Hospital Epidemiology|November 15, 2013
Management of neurosurgical instruments and patients exposed to Creutzfeldt-Jakob diseaseErmias D Belay, Jennifer Blase, Lynne M Sehulster, et al.
Chemical Biology & Drug Design|February 12, 2009
A potent gelatinase inhibitor with anti-tumor-invasive activity and its metabolic dispositionMijoon Lee, Giuseppe Celenza, Bill Boggess, et al.
Ebiomedicine|September 25, 2024
Crowd-sourced machine learning prediction of long COVID using data from the National COVID Cohort CollaborativeTimothy Bergquist, Johanna Loomba, Emily Pfaff, et al.
Pageof 1